233 related articles for article (PubMed ID: 10590124)
1. Adenovirus vector pseudotyping in fiber-expressing cell lines: improved transduction of Epstein-Barr virus-transformed B cells.
Von Seggern DJ; Huang S; Fleck SK; Stevenson SC; Nemerow GR
J Virol; 2000 Jan; 74(1):354-62. PubMed ID: 10590124
[TBL] [Abstract][Full Text] [Related]
2. Selective targeting of human cells by a chimeric adenovirus vector containing a modified fiber protein.
Stevenson SC; Rollence M; Marshall-Neff J; McClelland A
J Virol; 1997 Jun; 71(6):4782-90. PubMed ID: 9151872
[TBL] [Abstract][Full Text] [Related]
3. A mosaic adenovirus possessing serotype Ad5 and serotype Ad3 knobs exhibits expanded tropism.
Takayama K; Reynolds PN; Short JJ; Kawakami Y; Adachi Y; Glasgow JN; Rots MG; Krasnykh V; Douglas JT; Curiel DT
Virology; 2003 May; 309(2):282-93. PubMed ID: 12758175
[TBL] [Abstract][Full Text] [Related]
4. A mosaic fiber adenovirus serotype 5 vector containing reovirus sigma 1 and adenovirus serotype 3 knob fibers increases transduction in an ovarian cancer ex vivo system via a coxsackie and adenovirus receptor-independent pathway.
Tsuruta Y; Pereboeva L; Glasgow JN; Rein DT; Kawakami Y; Alvarez RD; Rocconi RP; Siegal GP; Dent P; Fisher PB; Curiel DT
Clin Cancer Res; 2007 May; 13(9):2777-83. PubMed ID: 17473211
[TBL] [Abstract][Full Text] [Related]
5. Subgroup B and F fiber chimeras eliminate normal adenovirus type 5 vector transduction in vitro and in vivo.
Schoggins JW; Gall JG; Falck-Pedersen E
J Virol; 2003 Jan; 77(2):1039-48. PubMed ID: 12502819
[TBL] [Abstract][Full Text] [Related]
6. Targeting adenovirus to the serotype 3 receptor increases gene transfer efficiency to ovarian cancer cells.
Kanerva A; Mikheeva GV; Krasnykh V; Coolidge CJ; Lam JT; Mahasreshti PJ; Barker SD; Straughn M; Barnes MN; Alvarez RD; Hemminki A; Curiel DT
Clin Cancer Res; 2002 Jan; 8(1):275-80. PubMed ID: 11801569
[TBL] [Abstract][Full Text] [Related]
7. Influence of fiber detargeting on adenovirus-mediated innate and adaptive immune activation.
Schoggins JW; Nociari M; Philpott N; Falck-Pedersen E
J Virol; 2005 Sep; 79(18):11627-37. PubMed ID: 16140740
[TBL] [Abstract][Full Text] [Related]
8. A human adenoviral vector with a chimeric fiber from canine adenovirus type 1 results in novel expanded tropism for cancer gene therapy.
Stoff-Khalili MA; Rivera AA; Glasgow JN; Le LP; Stoff A; Everts M; Tsuruta Y; Kawakami Y; Bauerschmitz GJ; Mathis JM; Pereboeva L; Seigal GP; Dall P; Curiel DT
Gene Ther; 2005 Dec; 12(23):1696-706. PubMed ID: 16034451
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus vectors containing chimeric type 5 and type 35 fiber proteins exhibit altered and expanded tropism and increase the size limit of foreign genes.
Mizuguchi H; Hayakawa T
Gene; 2002 Feb; 285(1-2):69-77. PubMed ID: 12039033
[TBL] [Abstract][Full Text] [Related]
10. Genetic retargeting of adenovirus: novel strategy employing "deknobbing" of the fiber.
Magnusson MK; Hong SS; Boulanger P; Lindholm L
J Virol; 2001 Aug; 75(16):7280-9. PubMed ID: 11462000
[TBL] [Abstract][Full Text] [Related]
11. A lentiviral vector-based adenovirus fiber-pseudotyping approach for expedited functional assessment of candidate retargeted fibers.
Uil TG; de Vrij J; Vellinga J; Rabelink MJ; Cramer SJ; Chan OY; Pugnali M; Magnusson M; Lindholm L; Boulanger P; Hoeben RC
J Gene Med; 2009 Nov; 11(11):990-1004. PubMed ID: 19757488
[TBL] [Abstract][Full Text] [Related]
12. Targeting adenovirus to CD80 and CD86 receptors increases gene transfer efficiency to malignant glioma cells.
Ulasov IV; Rivera AA; Han Y; Curiel DT; Zhu ZB; Lesniak MS
J Neurosurg; 2007 Sep; 107(3):617-27. PubMed ID: 17886563
[TBL] [Abstract][Full Text] [Related]
13. A helper-independent adenovirus vector with E1, E3, and fiber deleted: structure and infectivity of fiberless particles.
Von Seggern DJ; Chiu CY; Fleck SK; Stewart PL; Nemerow GR
J Virol; 1999 Feb; 73(2):1601-8. PubMed ID: 9882366
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of adenovirus vector entry into CD70-positive B-cell Lines by using a bispecific CD70-adenovirus fiber antibody.
Israel BF; Pickles RJ; Segal DM; Gerard RD; Kenney SC
J Virol; 2001 Jun; 75(11):5215-21. PubMed ID: 11333903
[TBL] [Abstract][Full Text] [Related]
15. An adenovirus type 5 (Ad5) amplicon-based packaging cell line for production of high-capacity helper-independent deltaE1-E2-E3-E4 Ad5 vectors.
Catalucci D; Sporeno E; Cirillo A; Ciliberto G; Nicosia A; Colloca S
J Virol; 2005 May; 79(10):6400-9. PubMed ID: 15858023
[TBL] [Abstract][Full Text] [Related]
16. Adenoviral serotype 5 vectors pseudotyped with fibers from subgroup D show modified tropism in vitro and in vivo.
Denby L; Work LM; Graham D; Hsu C; von Seggern DJ; Nicklin SA; Baker AH
Hum Gene Ther; 2004 Nov; 15(11):1054-64. PubMed ID: 15610606
[TBL] [Abstract][Full Text] [Related]
17. Complex mosaicism is a novel approach to infectivity enhancement of adenovirus type 5-based vectors.
Borovjagin AV; Krendelchtchikov A; Ramesh N; Yu DC; Douglas JT; Curiel DT
Cancer Gene Ther; 2005 May; 12(5):475-86. PubMed ID: 15706356
[TBL] [Abstract][Full Text] [Related]
18. Abolition of hCAR-dependent cell tropism using fiber knobs of Atadenovirus serotypes.
Renaut L; Colin M; Leite JP; Benko M; D'Halluin JC
Virology; 2004 Apr; 321(2):189-204. PubMed ID: 15051380
[TBL] [Abstract][Full Text] [Related]
19. Fiber-modified adenoviruses for targeted gene therapy.
Wu H; Curiel DT
Methods Mol Biol; 2008; 434():113-32. PubMed ID: 18470642
[TBL] [Abstract][Full Text] [Related]
20. Flexibility of the adenovirus fiber is required for efficient receptor interaction.
Wu E; Pache L; Von Seggern DJ; Mullen TM; Mikyas Y; Stewart PL; Nemerow GR
J Virol; 2003 Jul; 77(13):7225-35. PubMed ID: 12805421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
